Second generation model for prednisolone pharmacodynamics in the rat

An improved model describing receptor/gene-mediated pharmacodynamics of prednisolone is presented which consists of seven differential equations. Data for plasma prednisolone concentrations, free hepatic glucocorticoid receptors, and hepatic tyrosine aminotransferase activity (TAT) following low (5 mg/kg) and high (50 mg/kg) doses of prednisolone are used to quantitate the kinetics and dynamics of this synthetic steroid in the rat. In contrast to the earlier model, the newer model provides for a coupling and simultaneous fitting of receptor and TAT data and is able to describe the recycling of receptors between cytosol and nucleus and the return of cytosolic receptors to baseline following glucocorticoid elimination. A numerical technique to determine the efficiency of TAT induction based on area under the curve calculations is presented, which supports the hypothesis that nonlinear dose-response effects are due to dose and time-dependent receptor depletion in the cytosol. Simulations are presented to examine the major determinants of corticosteroid effects and to compare the effects of single-and multiple-dose regimens in maximizing drug effects.

[1]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[2]  William J. Jusko,et al.  Receptor-mediated pharmacodynamics of prednisolone in the rat , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.

[4]  S. Taniguchi,et al.  Receptor dynamics and tyrosine aminotransferase induction during the course of chronic treatment of rats with glucocorticoid. , 1986, Endocrinologia japonica.

[5]  Harold G. Boxenbaum,et al.  Statistical estimations in pharmacokinetics , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  M. G. Low,et al.  Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors. , 1987, The Biochemical journal.

[7]  H. Samuels,et al.  Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. , 1985, The Journal of biological chemistry.

[8]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[9]  R. Ellul-Micallef The acute effects of corticosteroids in bronchial asthma. , 1982, European journal of respiratory diseases. Supplement.

[10]  L B Sheiner,et al.  Pharmacokinetic and pharmacodynamic modeling in vivo. , 1981, Critical reviews in bioengineering.

[11]  M. Izawa,et al.  Dynamics of glucocorticoid receptor and induction of tyrosine aminotransferase in rat liver. , 1982, Endocrinologia japonica.

[12]  C M Metzler,et al.  Bioavailability--a problem in equivalence. , 1974, Biometrics.

[13]  F. Frey,et al.  Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. , 1984, Journal of immunology.

[14]  G. Rousseau Control of gene expression by glucocorticoid hormones. , 1984, The Biochemical journal.

[15]  N. Holbrook,et al.  Glucocorticoid-receptor complexes in rat thymus cells. Rapid kinetic behavior and a cyclic model. , 1984, The Journal of biological chemistry.

[16]  D. Granner,et al.  Regulation of hepatoma tissue culture cell tyrosine aminotransferase messenger ribonucleic acid by dexamethasone. , 1980, Biochemistry.

[17]  N. Holbrook,et al.  Steroid hormone antagonism and a cyclic model of receptor kinetics. , 1987, Journal of steroid biochemistry.

[18]  K. Fuxe,et al.  Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. , 1987, Endocrine reviews.

[19]  B. O’Malley,et al.  Mechanisms of action of steroid hormones. , 1971, The New England journal of medicine.